Save your place

Sign in to WhoBought

Please try again later.

Larimar Therapeutics, Inc. (LRMR) institutional ownership

Market cap$220M SectorHealthcare
Funds holding · Q1 2026
153
reported LRMR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
97 buyers · 56 sellers

Larimar Therapeutics, Inc. (LRMR) price and institutional activity

Dates

Q1 2026

$0 bought by 97 investors
Deerfield Management Company, L.P.Driehaus Capital Management LLC +95 more
$0 sold by 56 investors
Rtw Investments, LPMillennium Management LLC +54 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Larimar Therapeutics, Inc. (LRMR) institutional activity · 153

Investor Type Est. change Change Δ Own Date
Deerfield Management Company, L.P. · Added
Change +5.0M Date Q1 2026
Deerfield Management Company, L.P. Added· Q1 2026 +5.0M Q1 2026
Driehaus Capital Management LLC · Added
Change +2.4M Date Q1 2026
Driehaus Capital Management LLC Added· Q1 2026 +2.4M Q1 2026
Rtw Investments, LP · Reduced
Change −1.6M Date Q1 2026
Rtw Investments, LP Reduced· Q1 2026 −1.6M Q1 2026
Millennium Management LLC · Reduced
Change −1.6M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −1.6M Q1 2026
Deep Track Capital, LP · New
Change +1.5M Date Q1 2026
Deep Track Capital, LP New· Q1 2026 +1.5M Q1 2026
Dafna Capital Management LLC · Added
Change +1.1M Date Q1 2026
Dafna Capital Management LLC Added· Q1 2026 +1.1M Q1 2026
Soleus Capital Management, L.P. · New
Change +1.1M Date Q1 2026
Soleus Capital Management, L.P. New· Q1 2026 +1.1M Q1 2026
Aigh Capital Management LLC · Added
Change +1.0M Date Q1 2026
Aigh Capital Management LLC Added· Q1 2026 +1.0M Q1 2026
Marshall Wace, LLP · New
Change +933K Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +933K Q1 2026
Qube Research & Technologies Ltd · New
Change +848K Date Q1 2026
Qube Research & Technologies Ltd New· Q1 2026 +848K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −848K −62.0% Q1 2026
Woodline Partners LP · Added
Change +600K Date Q1 2026
Woodline Partners LP Added· Q1 2026 +600K Q1 2026
Vanguard · Added
Change +579K Date Q1 2026
Vanguard Added· Q1 2026 +579K Q1 2026
Gem Investment Advisors, LLC · Added
Change +573K Date Q1 2026
Gem Investment Advisors, LLC Added· Q1 2026 +573K Q1 2026
Nuveen, LLC · Added
Change +570K Date Q1 2026
Nuveen, LLC Added· Q1 2026 +570K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 153

Famous investor activity in Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hamilton Thomas Edward · Director Buy +$167K
Price $3.34 Qty +50K Owned 715K ΔOwn +7.5% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Hamilton Thomas Edward Director Buy $3.34 +50K +$167K 715K +7.5% Jul 6, 2026 Jul 8, 2026
Flynn James E. · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Flynn James E. Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Leff Jonathan S. · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Leff Jonathan S. Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Sherman Jeffrey W. · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Sherman Jeffrey W. Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Truitt Joseph · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Truitt Joseph Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Thomas Frank E. · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Thomas Frank E. Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Hamilton Thomas Edward · Director Grant (A) 55K
Owned 55K Trade date May 19, 2026 Filed date May 20, 2026
Hamilton Thomas Edward Director Grant (A) 55K 55K May 19, 2026 May 20, 2026
Deerfield Mgmt Hif, L.P. · Director, 10% Owner, Other 4 operations +$25M
Price $5.00 Qty +5.0M Owned 10.6M Trade date Feb 27, 2026 Filed date Mar 2, 2026
Deerfield Mgmt Hif, L.P. Director, 10% Owner, Other 4 operations $5.00 +5.0M +$25M 10.6M Feb 27, 2026 Mar 2, 2026
Hamilton Thomas Edward · Director Buy +$500K
Price $5.00 Qty +100K Owned 665K Trade date Feb 27, 2026 Filed date Mar 2, 2026
Hamilton Thomas Edward Director Buy $5.00 +100K +$500K 665K Feb 27, 2026 Mar 2, 2026
Thomas Frank E. · Director Buy +$25K
Price $5.00 Qty +5K Owned 7K Trade date Feb 27, 2026 Filed date Mar 2, 2026
Thomas Frank E. Director Buy $5.00 +5K +$25K 7K Feb 27, 2026 Mar 2, 2026
Sherman Jeffrey W. · Director Buy +$25K
Price $5.00 Qty +5K Owned 5K Trade date Feb 27, 2026 Filed date Mar 2, 2026
Sherman Jeffrey W. Director Buy $5.00 +5K +$25K 5K Feb 27, 2026 Mar 2, 2026
Shankar Gopi · Officer 2 operations 179K
Owned 154K Trade date Jan 26, 2026 Filed date Jan 27, 2026
Shankar Gopi Officer 2 operations 179K 154K Jan 26, 2026 Jan 27, 2026
Clayton Russell · Officer 2 operations 179K
Owned 154K Trade date Jan 26, 2026 Filed date Jan 27, 2026
Clayton Russell Officer 2 operations 179K 154K Jan 26, 2026 Jan 27, 2026
Ben-Maimon Carole · Director, Officer 2 operations 701K
Owned 601K Trade date Jan 26, 2026 Filed date Jan 27, 2026
Ben-Maimon Carole Director, Officer 2 operations 701K 601K Jan 26, 2026 Jan 27, 2026
Celano Michael · Officer 2 operations 263K
Owned 226K Trade date Jan 26, 2026 Filed date Jan 27, 2026
Celano Michael Officer 2 operations 263K 226K Jan 26, 2026 Jan 27, 2026
15 of 16
15 of 16 Sign in to continue to older insider transactions.

Larimar Therapeutics, Inc. (LRMR) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blue Owl Capital Holdings LP 10.7M
% of shares outstanding 10.0% Filing date May 14, 2026
Blue Owl Capital Holdings LP 10.7M 10.0% May 14, 2026
Flynn James E 6.2M
% of shares outstanding 9.6% Filing date Mar 15, 2024
Flynn James E 6.2M 9.6% Mar 15, 2024
Ra Capital Management, L.P. 6.0M
% of shares outstanding 9.5% Filing date Feb 26, 2024
Ra Capital Management, L.P. 6.0M 9.5% Feb 26, 2024
Janus Henderson Group PLC 5.6M
% of shares outstanding 8.7% Filing date Nov 14, 2024
Janus Henderson Group PLC 5.6M 8.7% Nov 14, 2024
Goldman Sachs Group Inc 4.5M
% of shares outstanding 7.0% Filing date Nov 6, 2024
Goldman Sachs Group Inc 4.5M 7.0% Nov 6, 2024
Opaleye Management, Inc. 4.0M
% of shares outstanding 6.2% Filing date Apr 16, 2025
Opaleye Management, Inc. 4.0M 6.2% Apr 16, 2025
Millennium Management LLC 3.6M
% of shares outstanding 3.5% Filing date Apr 30, 2026
Millennium Management LLC 3.6M 3.5% Apr 30, 2026
Verition Fund Management LLC 594K
% of shares outstanding 0.9% Filing date Nov 14, 2024
Verition Fund Management LLC 594K 0.9% Nov 14, 2024
8 of 9

Larimar Therapeutics, Inc. (LRMR) ownership FAQ

Who owns LRMR?

153 reporting institutions disclosed LRMR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.